Evaluating ferumoxytol for treating iron deficiency anemia in children
Official title: A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Run by AMAG Pharmaceuticals, Inc. · NCT03893045 · Data updated 2026-11-12
This study is testing if a new iron treatment called ferumoxytol works better than the usual iron sucrose for kids with iron deficiency anemia.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 2 Years to 17 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | AMAG Pharmaceuticals, Inc. Industry-sponsored |
| Locations | 15 sites (Little Rock, Arkansas and 14 other locations) |
| Status | Recruiting |
| Started | September 18, 2019 |
| Main results expected | July 2026 |
| Study ends | October 2026 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT03893045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pediatric patients aged 2 to less than 18 years diagnosed with iron deficiency anemia who have not responded well to oral iron therapy.
✕Probably not a fit
Patients with chronic kidney disease or those who have a known hypersensitivity to ferumoxytol or iron sucrose may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3, randomized, open-label study involves pediatric subjects aged 2 to less than 18 years with iron deficiency anemia (IDA). Participants will be randomly assigned to receive either ferumoxytol or iron sucrose, with treatment regimens designed to assess the efficacy and safety of these interventions. The study will monitor hemoglobin levels and adverse events over a period of five weeks following treatment. The aim is to determine the effectiveness of ferumoxytol compared to traditional iron sucrose therapy in this population.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for children suffering from iron deficiency anemia.
How similar studies have gone: Other studies have shown promising results with ferumoxytol in treating iron deficiency anemia, indicating a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Male or female 2 years to \<18 years of age at time of consent
2. Has IDA defined as:
1. Hemoglobin (Hgb) \<11.0 g/dL AND
2. Any one or more of the following:
* Transferrin saturation (TSAT) \<20%
* ferritin \<100 ng/mL
3. Documented history of unsatisfactory oral iron therapy or in whom oral iron cannot be tolerated, or for whom oral iron is considered medically inappropriate
Exclusion Criteria:
1. Known hypersensitivity reaction to any component of ferumoxytol or iron sucrose
2. History of allergy to intravenous (IV) iron
3. History of ≥2 clinically significant drug allergies
4. Subjects with CKD (defined as eGFR of \<60 mL/min/1.73 m2 or a requirement for chronic hemodialysis or peritoneal dialysis during Screening)
5. Low systolic blood pressure (BP) (age 1 to 9 years \<70 + \[age in years x 2\] mmHg, age 10 to 17 years \<90 mmHg)
6. Hgb ≤7.0 g/dL
7. Serum ferritin level \>600 ng/mL
Where it's running
-
Optimus U Corporation
Miami, Florida, United States Recruiting -
Biomedical Research LLC
Miami, Florida, United States Recruiting -
Sun Research Institute
San Antonio, Texas, United States Recruiting -
Arkansas Children's Hospital
Little Rock, Arkansas, United States Not yet recruiting -
University of Florida
Gainesville, Florida, United States Not yet recruiting -
Gwinnett Research Institute
Buford, Georgia, United States Not yet recruiting
Show 9 more locations
-
JSC Saules seimos medicinos centras
Kaunas, Lithuania Not yet recruiting -
Klaipeda Children's Hospital
Klaipėda, Lithuania Not yet recruiting -
Children's Hospital-Affiliate of Vilnius University Hospital Santariskiu Klinikos
Vilnius, Lithuania Not yet recruiting -
Osrodek Badan Klinicznych In Vivo sp. z o.o.
Bydgoszcz, Poland Not yet recruiting -
Prywatny Gabinet Lekarski Dr N. med. Jerzy Brzostek
Dębica, Poland Not yet recruiting -
Pro Familia Altera Sp. z o.o.
Katowice, Poland Not yet recruiting -
Korczowski Bartosz, Gabinet Lekarski
Rzeszów, Poland Not yet recruiting -
Centrum Zdrowia MDM
Warsaw, Poland Not yet recruiting -
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Wroclaw, Poland Not yet recruiting
Study contacts
- Study coordinator: Clinical Trial Interest
- Email: CTInterest@covispharma.com
- Phone: 1-877-374 -4177
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Preconception versus early-pregnancy iron screening and treatment
This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.
-
Ferric derisomaltose injection in adults with iron deficiency anemia under fasting conditions
This study tests whether a ferric derisomaltose injection given to adults with iron deficiency anemia in a fasting state works similarly to a reference product and is safe to use.
-
FACE-APPS approach to improve iron in adolescent girls in marginalized communities
This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.
-
Acupoint TENS vs. Resistance Training for Iron Deficiency Anemia in Women
This trial tests whether acupoint transcutaneous electrical nerve stimulation (Acu-TENS) or resistance exercise, in addition to standard care, can raise hemoglobin levels in women with iron deficiency anemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.